Skip to Content

625 Results Found

  • Review
  • Open Access
2 Citations
4,501 Views
15 Pages

Therapeutic recombinant proteins are powerful tools used for the treatment of many detrimental diseases such as diabetes, cancer, multiple sclerosis, rheumatoid arthritis, hepatitis, and many more. Their importance in disease therapy is growing over...

(This article belongs to the Section Molecular and Translational Medicine)
  • Review
  • Open Access
45 Citations
9,467 Views
12 Pages

11 June 2021

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness among older adults in the Western world. While therapies exist for patients with exudative AMD, there are currently no approved therapies for non-exudative AMD and it...

(This article belongs to the Special Issue Age-Related Macular Degeneration: Advances in Management and Diagnosis)
  • Review
  • Open Access
18 Citations
10,442 Views
16 Pages

31 August 2024

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare and potentially life-threatening hematologic disorder caused by a somatic mutation in a relevant portion of hematopoietic stem cells. Mutation of the phosphatidylinositol glycan biosynthesis class A...

(This article belongs to the Special Issue Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Novel Therapeutic Approaches)
  • Review
  • Open Access
5 Citations
5,985 Views
18 Pages

Complement Inhibitors and the Risk of (Breakthrough) Infections—Critical Analysis and Preventive Strategies

  • Nikola Halacova,
  • Miroslava Brndiarova,
  • Branislav Slenker,
  • Anna Ruzinak Bobcakova and ,
  • Martina Schniederova,
  • Adam Markocsy,
  • Ingrid Urbancikova and
  • Milos Jesenak
  • + 3 authors+ 0 author

The complement system is a key component of innate immunity, responsible for mediating the rapid clearance of pathogens and coordinating adaptive immune responses. Although complement activation is essential for effective infection control and preven...

(This article belongs to the Section Monoclonal Antibodies)
  • Systematic Review
  • Open Access
12 Citations
4,621 Views
28 Pages

Complement Inhibitors for Geographic Atrophy in Age-Related Macular Degeneration—A Systematic Review

  • Ana Maria Dascalu,
  • Catalin Cicerone Grigorescu,
  • Dragos Serban,
  • Corneliu Tudor and ,
  • Cristina Alexandrescu,
  • Daniela Stana,
  • Sanda Jurja,
  • Andreea Cristina Costea,
  • Catalin Alius and
  • Bogdan Mihai Cristea
  • + 8 authors+ 3 authors

17 September 2024

Background/Objectives: Age-related macular degeneration (AMD) is one of the main causes of blindness and visual impairment worldwide. Intravitreal complement inhibitors are an emergent approach in the treatment of AMD, which have had encouraging resu...

(This article belongs to the Special Issue Personalized Diagnosis and Therapies in Retinal Diseases)
  • Article
  • Open Access
13 Citations
5,825 Views
15 Pages

25 April 2018

The complement system is a part of the innate immune system that viruses need to face during infections. Many viruses incorporate cellular regulators of complement activation (RCA) to block complement pathways and our prior work has shown that Parain...

(This article belongs to the Section Animal Viruses)
  • Review
  • Open Access
27 Citations
6,350 Views
11 Pages

4 August 2023

Geographic atrophy (GA) affects around 5 million individuals worldwide. Genome-wide, histopathologic, in vitro and animal studies have implicated the activation of the complement system and chronic local inflammation in the pathogenesis of GA. Recent...

(This article belongs to the Section Ophthalmology)
  • Article
  • Open Access
46 Citations
17,937 Views
17 Pages

mRNA-LNP COVID-19 Vaccine Lipids Induce Complement Activation and Production of Proinflammatory Cytokines: Mechanisms, Effects of Complement Inhibitors, and Relevance to Adverse Reactions

  • Tamás Bakos,
  • Tamás Mészáros,
  • Gergely Tibor Kozma,
  • Petra Berényi and ,
  • Réka Facskó,
  • Henriette Farkas,
  • László Dézsi,
  • Carlo Heirman,
  • Stefaan de Koker and
  • János Szebeni
  • + 9 authors+ 4 authors

A small fraction of people vaccinated with mRNA–lipid nanoparticle (mRNA-LNP)-based COVID-19 vaccines display acute or subacute inflammatory symptoms whose mechanism has not been clarified to date. To better understand the molecular mechanism o...

(This article belongs to the Section Molecular Immunology)
  • Article
  • Open Access
10 Citations
5,349 Views
15 Pages

Complement Inhibitors in Generalized Myasthenia Gravis: Comparison of Administration Schedules, Efficacy, and Safety

  • Giuseppe Di Martino,
  • Nicasio Rini,
  • Alessia Bonaventura,
  • Mauro Trovato and ,
  • Simona Maccora,
  • Salvatore Maria Lima,
  • Concetta La Seta,
  • Filippo Brighina and
  • Vincenzo Di Stefano
  • + 4 authors+ 0 author

19 November 2025

Background: Eculizumab, Ravulizumab, and Zilucoplan are inhibitors of terminal complement protein C5 (C5IT) approved for the treatment of generalized Myasthenia Gravis (gMG). The aim of this study is to compare the administration schedules, efficacy,...

(This article belongs to the Special Issue Clinical Care and Rehabilitation for Neuromuscular Diseases)
  • Article
  • Open Access
13 Citations
6,803 Views
18 Pages

Discovery of APL-1030, a Novel, High-Affinity Nanofitin Inhibitor of C3-Mediated Complement Activation

  • Joshua Garlich,
  • Mathieu Cinier,
  • Anne Chevrel,
  • Anaëlle Perrocheau and ,
  • David J. Eyerman,
  • Mark Orme,
  • Olivier Kitten and
  • Lukas Scheibler
  • + 3 authors+ 0 author

11 March 2022

Uncontrolled complement activation contributes to multiple immune pathologies. Although synthetic compstatin derivatives targeting C3 and C3b are robust inhibitors of complement activation, their physicochemical and molecular properties may limit acc...

(This article belongs to the Topic Compounds with Medicinal Value)
  • Article
  • Open Access
3 Citations
2,199 Views
15 Pages

2 December 2024

Chronic stress, a risk factor for many neuropsychiatric conditions, causes dysregulation in the immune system in both humans and animal models. Additionally, inflammation and synapse loss have been associated with deficits in social behavior. The com...

(This article belongs to the Special Issue Neuroinflammation in Brain Health and Diseases)
  • Article
  • Open Access
1,015 Views
21 Pages

In Vivo Efficacy of an Inhibitor of Complement and FcRn in Models of Glomerulonephritis and Collagen-Induced Arthritis Using Human C2 Knock-In Mice

  • Helen Cao,
  • Amelia Nash,
  • Yun Dai,
  • Arthur Hsu and ,
  • Amanda L. Turner,
  • Kaushala Jayawardana,
  • Sharon Vyas,
  • Adele Barr,
  • Sandra Wymann and
  • Matthew P. Hardy
  • + 5 authors+ 0 author

A therapeutic antibody, CSL305, has been developed, which combines inhibition of the complement classical and lectin pathways via complement C2 binding with an ability to act as an antagonist of the neonatal Fc receptor (FcRn). CSL305 binds to human...

(This article belongs to the Special Issue Targeting Metabolism, Inflammation, and Oxidative Stress: Novel Therapeutic Approaches in Human Diseases)
  • Systematic Review
  • Open Access
2 Citations
1,828 Views
22 Pages

Efficacy and Safety of Treatments for Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review

  • Shreyans Gandhi,
  • Isobel Munro,
  • Victoria Shodimu,
  • Neil Webb and ,
  • Katharina Pannagl,
  • Anggie Wiyani and
  • Maria-Magdalena Balp
  • + 2 authors+ 0 author

29 May 2026

Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare blood disorder characterized by complement-mediated hemolytic anemia and thrombosis. The first treatments approved were complement 5 inhibitors (C5is), eculizumab and ravulizumab. Recent...

(This article belongs to the Section Hematology)
  • Review
  • Open Access
5 Citations
6,049 Views
17 Pages

Paroxysmal Nocturnal Hemoglobinuria: Unraveling Its Molecular Pathogenesis and Advancing Targeted Therapeutic Strategies

  • Elisavet Apostolidou,
  • Vasileios Georgoulis,
  • Dimitrios Leonardos,
  • Eleni Kapsali and
  • Eleftheria Hatzimichael

9 September 2025

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare, acquired clonal hematologic disorder caused by somatic mutations in the PIGA gene of hematopoietic stem cells, leading to the absence of GPI-anchored proteins, including the complement regulators C...

(This article belongs to the Section Oncology)
  • Perspective
  • Open Access
15 Citations
8,796 Views
16 Pages

Paroxysmal nocturnal hemoglobinuria (PNH) is a rare disease characterized by complement-mediated hemolysis and potentially life-threatening complications. Pegcetacoplan, an inhibitor of complement components C3 and C3b, was approved by the US Food an...

(This article belongs to the Special Issue Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Novel Therapeutic Approaches)
  • Article
  • Open Access
15 Citations
6,173 Views
29 Pages

Design and Selection of Novel C1s Inhibitors by In Silico and In Vitro Approaches

  • Katalin Szilágyi,
  • István Hajdú,
  • Beáta Flachner,
  • Zsolt Lőrincz and ,
  • Júlia Balczer,
  • Péter Gál,
  • Péter Závodszky,
  • Chiara Pirli,
  • Balázs Balogh and
  • György Dormán
  • + 7 authors+ 2 authors

9 October 2019

The complement system is associated with various diseases such as inflammation or auto-immune diseases. Complement-targeted drugs could provide novel therapeutic intervention against the above diseases. C1s, a serine protease, plays an important role...

(This article belongs to the Special Issue Recent Trends on Enzymes Inhibitors and Activators in Drug Research II)
  • Article
  • Open Access
6 Citations
1,994 Views
21 Pages

Targeting the Kynureninase–HDAC6–Complement Axis as a Novel Therapeutic Strategy in Glioblastoma

  • Arif Ul Hasan,
  • Sachiko Sato,
  • Mami Obara,
  • Yukiko Kondo and
  • Eiichi Taira

Background/Objectives: Glioblastoma (GBM) is an aggressive brain tumor known for its profound heterogeneity and treatment resistance. Dysregulated complement signaling and epigenetic alterations have been implicated in GBM progression. This study ide...

  • Review
  • Open Access
7 Citations
7,048 Views
19 Pages

Myasthenia gravis (MG) is a chronic autoimmune disorder characterized by fluctuating skeletal muscle weakness. Myasthenic crisis (MCr), a severe and potentially life-threatening complication, presents with respiratory failure and requires intensive c...

(This article belongs to the Section Movement Disorders and Neurodegenerative Diseases)
  • Systematic Review
  • Open Access
657 Views
15 Pages

Targeted Therapies in Generalized Myasthenia Gravis: An Umbrella Review of Evidence Quality and Overlap

  • Felipe Castillo,
  • Macarena Morel-Marambio,
  • Francisco Pérez-Mora,
  • Luis Ortíz-Muñoz and ,
  • Gabriel Bustamante,
  • Francisca Fajre and
  • Gabriel Cea
  • + 2 authors+ 0 author

30 September 2026

Generalized myasthenia gravis (gMG) is an antibody-mediated autoimmune disorder in which complement C5 inhibitors and neonatal Fc receptor (FcRn) antagonists have expanded therapeutic options, while rituximab remains used off-label in selected patien...

  • Article
  • Open Access
22 Citations
6,693 Views
16 Pages

Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function

  • Matthias A. Fante,
  • Sonja-Maria Decking,
  • Christina Bruss,
  • Stephan Schreml and ,
  • Peter J. Siska,
  • Marina Kreutz and
  • Kathrin Renner
  • + 2 authors+ 0 author

Heat-inactivation of sera is used to reduce possible disturbing effects of complement factors in cell-culture experiments, but it is controversially discussed whether this procedure is appropriate or could be neglected. Here, we report a strong impac...

(This article belongs to the Section Biochemistry)
  • Systematic Review
  • Open Access
1 Citations
2,280 Views
25 Pages

Comparative Efficacy and Safety of Pharmacological Interventions for IgA Nephropathy: A Systematic Review and Meta-Analysis

  • Abdulaziz Alroshodi,
  • Faisal A. Al-Harbi,
  • Mohanad A. Alkuwaiti,
  • Dalal M. Alabdulmohsen and ,
  • Hanin J. Mobarki,
  • Reem F. AlShammari,
  • Rewa L. Alsharif,
  • Hanan I. Wasaya,
  • Hussam J. Alshehri and
  • Ahmed Y. Azzam
  • + 5 authors+ 0 author

17 December 2025

Background and Objectives: IgA nephropathy represents the most prevalent form of primary glomerulonephritis around the world, with significant heterogeneity in management strategies and outcomes. We conducted a systematic review and meta-analysis to...

(This article belongs to the Section Urology & Nephrology)
  • Article
  • Open Access
4 Citations
5,950 Views
12 Pages

Peptide Inhibitor of Complement C1, RLS-0071, Reduces Zosteriform Spread of Herpes Simplex Virus Type 1 Skin Infection and Promotes Survival in Infected Mice

  • Maimoona S. Bhutta,
  • Daniel G. Sausen,
  • Kirstin M. Reed,
  • Elisa S. Gallo and ,
  • Pamela S. Hair,
  • Brittany P. Lassiter,
  • Neel K. Krishna,
  • Kenji M. Cunnion and
  • Ronen Borenstein
  • + 4 authors+ 0 author

22 July 2021

Herpes simplex virus type 1 (HSV-1) is a prevalent human pathogen primarily transmitted through skin-to-skin contact, especially on and around mucosal surfaces where there is contact with contaminated saliva during periods of viral shedding. It is es...

(This article belongs to the Special Issue Anti-herpesvirus Drugs and Vaccines)
  • Article
  • Open Access
8 Citations
5,847 Views
20 Pages

Targeting the Initiator Protease of the Classical Pathway of Complement Using Fragment-Based Drug Discovery

  • Blake R. Rushing,
  • Denise L. Rohlik,
  • Sourav Roy,
  • D. Andrew Skaff and
  • Brandon L. Garcia

3 September 2020

The initiating protease of the complement classical pathway, C1r, represents an upstream and pathway-specific intervention point for complement-related autoimmune and inflammatory diseases. Yet, C1r-targeted therapeutic development is currently under...

(This article belongs to the Special Issue Deep Learning for Molecular Structure Modelling)
  • Review
  • Open Access
29 Citations
19,258 Views
20 Pages

Atypical Hemolytic Uremic Syndrome: A Review of Complement Dysregulation, Genetic Susceptibility and Multiorgan Involvement

  • Razvan-George Bogdan,
  • Paula Anderco,
  • Cristian Ichim,
  • Anca-Maria Cimpean and ,
  • Samuel Bogdan Todor,
  • Mihai Glaja-Iliescu,
  • Zorin Petrisor Crainiceanu and
  • Mirela Livia Popa
  • + 3 authors+ 0 author

7 April 2025

Atypical hemolytic uremic syndrome (aHUS) is a rare, life-threatening thrombotic microangiopathy (TMA) characterized by complement dysregulation, leading to microvascular thrombosis and multi-organ injury. TMAs are defined by thrombocytopenia, microa...

(This article belongs to the Section Emergency Medicine)
  • Review
  • Open Access
46 Citations
9,488 Views
14 Pages

Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules

  • Marcella Nebbioso,
  • Alessandro Lambiase,
  • Alberto Cerini,
  • Paolo Giuseppe Limoli and ,
  • Maurizio La Cava and
  • Antonio Greco
  • + 1 author+ 0 author

The present review focuses on recent clinical trials that analyze the efficacy of intravitreal therapeutic agents for the treatment of dry age-related macular degeneration (AMD), such as neuroprotective drugs, and complement inhibitors, also called i...

(This article belongs to the Special Issue Molecular Biology of Age-Related Macular Degeneration (AMD))
  • Review
  • Open Access
28 Citations
9,275 Views
13 Pages

Transplant-associated thrombotic microangiopathy (TA-TMA) constitutes a significant contributor to the increased morbidity and mortality after allogenic hematopoietic stem cell transplantation (allo-HSCT). TA-TMA is a heterogenous disease, characteri...

(This article belongs to the Special Issue Molecular Advances in Thrombotic Microangiopathy and Thrombotic Complications)
  • Article
  • Open Access
4 Citations
7,652 Views
14 Pages

Refractory IgA Nephropathy: A Challenge for Future Nephrologists

  • Vincenzo Di Leo,
  • Francesca Annese,
  • Federica Papadia,
  • Maria Serena Russo and ,
  • Marica Giliberti,
  • Fabio Sallustio and
  • Loreto Gesualdo
  • + 2 authors+ 0 author

5 February 2024

IgA nephropathy (IgAN) represents the most prevalent form of primary glomerulonephritis, and, on a global scale, it ranks among the leading culprits behind end-stage kidney disease (ESKD). Presently, the primary strategy for managing IgAN revolves ar...

(This article belongs to the Special Issue Treatment of Refractory Glomerular Diseases: Challenges and Solutions)
  • Review
  • Open Access
12 Citations
9,899 Views
21 Pages

Complement System Inhibitors in Nephrology: An Update—Narrative Review

  • Mugurel Apetrii,
  • Alexandru Dan Costache,
  • Irina Iuliana Costache Enache,
  • Luminita Voroneanu and ,
  • Andreea Simona Covic,
  • Mehmet Kanbay and
  • Adrian Covic
  • + 2 authors+ 0 author

Complement system inhibitors are emerging as promising therapies in nephrology, particularly for diseases where complement dysregulation is central to pathogenesis. This review summarizes the role of complement activation in kidney diseases and curre...

(This article belongs to the Special Issue Recent Molecular Trends and Prospects in Kidney Diseases)
  • Review
  • Open Access
4 Citations
5,321 Views
15 Pages

Biologics and Non-Biologics Immunosuppressive Treatments for IgA Nephropathy in Both Adults and Children

  • Decimo Silvio Chiarenza,
  • Enrico Eugenio Verrina,
  • Edoardo La Porta,
  • Gianluca Caridi and ,
  • Gian Marco Ghiggeri,
  • Gabriele Mortari,
  • Francesca Lugani,
  • Andrea Angeletti and
  • Carolina Bigatti
  • + 4 authors+ 0 author

23 April 2024

Immunoglobulin A nephropathy represents the most prevalent cause of glomerulonephritis worldwide and may lead to renal failure in a relevant number of cases in both paediatric and adult subjects. Although their pathogenesis is still largely unclear,...

(This article belongs to the Section Nephrology & Urology)
  • Article
  • Open Access
1,930 Views
15 Pages

7 February 2026

Environmental lead (Pb) exposure remains a significant public health concern, and its association with cerebrovascular injury and Alzheimer’s disease (AD) is increasingly recognized. In this study, we demonstrated using an in vitro system that...

(This article belongs to the Section Neuroscience)
  • Review
  • Open Access
5 Citations
4,437 Views
17 Pages

Prevention and Management of Thromboembolism in Patients with Paroxysmal Nocturnal Hemoglobinuria in Asia: A Narrative Review

  • Yasutaka Ueda,
  • Wen-Chien Chou,
  • Yeow-Tee Goh,
  • Ponlapat Rojnuckarin and ,
  • Jin Seok Kim,
  • Raymond Siu Ming Wong,
  • Lily Lee Lee Wong,
  • Jun Ho Jang,
  • Tzeon-Jye Chiou and
  • Jong Wook Lee
  • + 6 authors+ 1 author

Thromboembolism (TE) is a major cause of morbidity and mortality in patients with paroxysmal nocturnal hemoglobinuria (PNH). This narrative review summarizes available evidence on TE in Asian patients with PNH and discusses practical considerations a...

(This article belongs to the Special Issue Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Novel Therapeutic Approaches)
  • Review
  • Open Access
36 Citations
13,833 Views
20 Pages

New Targeted Agents in Myasthenia Gravis and Future Therapeutic Strategies

  • Daniel Sánchez-Tejerina,
  • Javier Sotoca,
  • Arnau Llaurado,
  • Veronica López-Diego and ,
  • Raul Juntas-Morales and
  • Maria Salvado
  • + 1 author+ 0 author

28 October 2022

Myasthenia gravis (MG) is a chronic autoimmune disease for which multiple immunomodulatory therapies are available. Nevertheless, MG has a significant impact on patient quality of life. In recent years, experts’ main efforts have focused on opt...

(This article belongs to the Special Issue Update in the Management of Myasthenia Gravis)
  • Article
  • Open Access
2 Citations
3,089 Views
24 Pages

Real-World Evidence of the Disease Burden and Economic Impact of Paroxysmal Nocturnal Hemoglobinuria in Italy

  • Roberta Bini,
  • Lorena D’Anna,
  • Diletta Valsecchi,
  • Stefania Mazzoni and ,
  • Valentina Perrone and
  • Luca Degli Esposti
  • + 1 author+ 0 author

22 April 2025

Background/Objectives: This analysis was conducted in Italy to estimate the epidemiology of paroxysmal nocturnal hemoglobinuria (PNH) and to describe the features and economic burden of PHN in the adult population considering the role of anti-complem...

(This article belongs to the Section Epidemiology & Public Health)
  • Review
  • Open Access
3,729 Views
13 Pages

Updated Pathways in Cardiorenal Continuum after Kidney Transplantation

  • Agnė Laučytė-Cibulskienė,
  • Ali-Reza Biglarnia,
  • Carin Wallquist and
  • Anders Christensson

Cardiovascular disease (CVD) remains one of the leading causes for increased morbidity and mortality in chronic kidney disease (CKD). Kidney transplantation is the preferred treatment option for CKD G5. Improved perioperative and postoperative care,...

(This article belongs to the Special Issue Advances in Cardiovascular Complications After Renal Transplantation)
  • Article
  • Open Access
4 Citations
3,975 Views
12 Pages

New Immunohistochemical Markers for Pleural Mesothelioma Subtyping

  • Iosè Di Stefano,
  • Greta Alì,
  • Anello Marcello Poma,
  • Rossella Bruno and ,
  • Agnese Proietti,
  • Cristina Niccoli,
  • Carmelina Cristina Zirafa,
  • Franca Melfi,
  • Maria Giovanna Mastromarino and
  • Gabriella Fontanini
  • + 6 authors+ 1 author

14 September 2023

Pleural mesothelioma (PM) comprises three main subtypes: epithelioid, biphasic and sarcomatoid, which have different impacts on prognosis and treatment definition. However, PM subtyping can be complex given the inter- and intra-tumour morphological h...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
1 Citations
1,985 Views
10 Pages

Improved Iron Overload with Pegcetacoplan in Eculizumab-Experienced Patients with Paroxysmal Nocturnal Hemoglobinuria

  • Jamile Shammo,
  • Peter Hillmen,
  • Peter Blandino,
  • Vijay Abilash and
  • David J. Kuter

15 October 2025

Complement factor 5 (C5) inhibitors for paroxysmal nocturnal hemoglobinuria (PNH) may cause iron overload due to residual intravascular hemolysis (IVH) and emergent extravascular hemolysis (EVH). In PEGASUS (phase 3; NCT03500549), adults with PNH wit...

(This article belongs to the Special Issue Paroxysmal Nocturnal Hemoglobinuria: Pathophysiology and Novel Therapeutic Approaches)
  • Review
  • Open Access
18 Citations
12,956 Views
12 Pages

Difficult Cases of Paroxysmal Nocturnal Hemoglobinuria: Diagnosis and Therapeutic Novelties

  • Bruno Fattizzo,
  • Fabio Serpenti,
  • Juri Alessandro Giannotta and
  • Wilma Barcellini

1 March 2021

Paroxysmal nocturnal hemoglobinuria (PNH) is an intriguing disease that can pose many difficulties to physicians, as well as to hematologists, who are unfamiliar with it. Research regarding its pathophysiologic, diagnostic, and therapeutic aspects is...

(This article belongs to the Section Hematology)
  • Article
  • Open Access
589 Views
23 Pages

Neuroinflammatory Response to Postnatal Administration of Valproic Acid in Wistar Rats as a Mechanism for the Development of Autism Spectrum Disorders: The Role of Neutrophils

  • Anna Stakhanova,
  • Svetlana Zozulya,
  • Natalya Kost,
  • Olga Voskresenskaya and ,
  • Anastasiya Pozdnyakova,
  • Elena Cheremnykh,
  • Yulia Chaika and
  • Ekaterina Semina
  • + 3 authors+ 0 author

Background/Objectives: According to current concepts, neuroinflammation is one of the putative causes of autism spectrum disorders (ASD) development. However, the role of neutrophils in neuroinflammation remains insufficiently studied. The study was...

(This article belongs to the Section Developmental Neuroscience)
  • Article
  • Open Access
51 Citations
9,280 Views
16 Pages

Development of a Cell-Based Luciferase Complementation Assay for Identification of SARS-CoV-2 3CLpro Inhibitors

  • Jonathan M. O. Rawson,
  • Alice Duchon,
  • Olga A. Nikolaitchik,
  • Vinay K. Pathak and
  • Wei-Shau Hu

24 January 2021

The 3C-like protease (3CLpro) of SARS-CoV-2 is considered an excellent target for COVID-19 antiviral drug development because it is essential for viral replication and has a cleavage specificity distinct from human proteases. However, drug developmen...

(This article belongs to the Special Issue Pathogenesis of Human and Animal Coronaviruses)
  • Review
  • Open Access
18 Citations
12,559 Views
13 Pages

19 May 2021

Severe coronavirus disease 2019 causes multi-organ dysfunction with significant morbidity and mortality. Mounting evidence implicates maladaptive over-activation of innate immune pathways such as the complement cascade as well as endothelial dysfunct...

(This article belongs to the Section Immunology & Rheumatology)
  • Review
  • Open Access
18 Citations
4,701 Views
15 Pages

The management of exudative retinal diseases underwent a revolution due to the introduction of intravitreal treatments. There are two main classes of intravitreal drugs, namely anti-vascular endothelial growth factors (anti-VEGF) and corticosteroids...

(This article belongs to the Special Issue Recent Advances in Retinal Drug Delivery)
  • Review
  • Open Access
50 Citations
11,605 Views
35 Pages

Inflammation plays a central role in the pathogenesis of knee PTOA after knee trauma. While a comprehensive therapy capable of preventing or delaying post-traumatic osteoarthritis (PTOA) progression after knee joint injury does not yet clinically exi...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Review
  • Open Access
1,243 Views
15 Pages

New Insights in Diagnosis and Therapy of Paroxysmal Nocturnal Hemoglobinuria (PNH)

  • Francesco Lanza,
  • Evita Massari,
  • Barbara Castagnari,
  • Martina Cantelli and
  • Giorgio Zavagli

6 August 2026

PNH is an acquired ultrarare disease caused by a somatic mutation of PIGA gene located at band 22 of the short arm of the X chromosome, which is unable to carry out the synthesis of glycosil-phosphatidyl-inositol. The loss of complement regulators CD...

(This article belongs to the Special Issue Bone Marrow Failure and Leukemia Predisposition Syndromes)
  • Article
  • Open Access
19 Citations
7,686 Views
22 Pages

When excessively activated, C1 is insufficiently regulated, which results in tissue damage. Such tissue damage causes the complement system to become further activated to remove the resulting tissue damage, and a vicious cycle of activation/tissue da...

(This article belongs to the Special Issue Machine Learning for Molecular Modelling in Drug Design)
  • Brief Report
  • Open Access
8 Citations
6,157 Views
13 Pages

Allosteric Kinase Inhibitors Reshape MEK1 Kinase Activity Conformations in Cells and In Silico

  • Jakob Fleischmann,
  • Andreas Feichtner,
  • Louis DeFalco,
  • Valentina Kugler and ,
  • Selina Schwaighofer,
  • Roland G Huber and
  • Eduard Stefan
  • + 2 authors+ 0 author

30 March 2021

Mutations at different stages of the mitogen-activated protein kinase (MAPK) signaling pathway lead to aberrant activation of the involved protein kinase entities. These oncogenic modifications alter signal propagation which converge on the gatekeepe...

(This article belongs to the Special Issue Recent Insights into the Regulation and Structure of RAS Membrane Signaling Complexes—Emerging Drug Targeting Opportunities)
  • Review
  • Open Access
34 Citations
11,643 Views
20 Pages

12 March 2025

The antibody, linker, and payload moieties all play a significant role in giving the ADC its unique therapeutic potential. The antibody subclass employed in ADCs is determined based on relative individual receptor affinities and pharmacokinetics. Mea...

(This article belongs to the Section Cancer Drug Development)
  • Protocol
  • Open Access
1 Citations
3,743 Views
10 Pages

Benefits and Harms of Treatment and Preventive Interventions for Hereditary Angioedema: Protocol for a Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

  • Mati Chuamanochan,
  • Sutthinee Phuprasertsak,
  • Puncharas Weesasubpong,
  • Chidchanok Ruengorn and ,
  • Chabaphai Phosuya,
  • Ratanaporn Awiphan,
  • Brian Hutton,
  • Kednapa Thavorn,
  • Jonathan A. Bernstein and
  • Surapon Nochaiwong
  • + 5 authors+ 0 author

22 May 2022

Background: Hereditary angioedema (HAE) is a rare genetic disease that can lead to potentially life-threatening airway attacks. Although novel therapies for HAE treatment have become available over the past decades, a comparison of all available trea...

(This article belongs to the Special Issue Autoimmunity and Genetic Syndromes)
  • Review
  • Open Access
33 Citations
12,929 Views
18 Pages

Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives

  • Cristina Giorgio,
  • Mara Zippoli,
  • Pasquale Cocchiaro,
  • Vanessa Castelli and ,
  • Giustino Varrassi,
  • Andrea Aramini,
  • Marcello Allegretti,
  • Laura Brandolini and
  • Maria Candida Cesta
  • + 4 authors+ 0 author

The complement system is a key component of innate immunity since it plays a critical role in inflammation and defense against common pathogens. However, an inappropriate activation of the complement system is involved in numerous disorders, includin...

(This article belongs to the Special Issue Neuropathic Pain: Therapy and Mechanisms)
  • Review
  • Open Access
16 Citations
8,035 Views
23 Pages

Nanobodies Provide Insight into the Molecular Mechanisms of the Complement Cascade and Offer New Therapeutic Strategies

  • Alessandra Zarantonello,
  • Henrik Pedersen,
  • Nick S. Laursen and
  • Gregers R. Andersen

17 February 2021

The complement system is part of the innate immune response, where it provides immediate protection from infectious agents and plays a fundamental role in homeostasis. Complement dysregulation occurs in several diseases, where the tightly regulated p...

(This article belongs to the Special Issue The Therapeutic and Diagnostic Potential of Nanobodies)
  • Article
  • Open Access
2 Citations
1,945 Views
12 Pages

Association of Endothelial Cell Activation with Acute Kidney Injury during Coronary Angiography and the Influence of Recombinant Human C1 Inhibitor—A Secondary Analysis of a Randomized, Placebo-Controlled, Double-Blind Trial

  • Stephan Moser,
  • Laura Araschmid,
  • Anneza Panagiotou,
  • Leo H. Bonati and ,
  • Tobias Breidthardt,
  • Gregor Fahrni,
  • Christoph Kaiser,
  • Raban Jeger,
  • Marten Trendelenburg and
  • Michael Osthoff
  • + 5 authors+ 0 author

Background: Acute kidney injury (AKI) as a result of iodinated contrast media (CM) has been linked to CM-induced renal ischemia and toxic effects on endothelial cells (EC). The recombinant human C1 inhibitor (rhC1INH) has been shown to influence EC a...

(This article belongs to the Section Molecular and Translational Medicine)

of 13